Anyone know the $16 stock that will revolutionize organ transplants as teased to see some newsletter, Prof Litman, Altimetry, I am being pitched by Tilson and Standsberry
Articles
Monthly newsletter providing small-cap stock recommendations aimed at individual investors, recommendations are based on “hidden value” he sees using the UAFRS accounting adjustments developed by his Valens Research company for institutional subscribers.
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Just want to share this news about KEYS, the company is mainly perceived as a pure hardware play, but 20% of the offerin...
Altimetry has a great product for checking stocks viability. Unluckily they are using the concept that what a company i...
SQ was one of the stocks on the don't buy list from Altimetry (forensic accounting) few days ago...